| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |